Mesothelin positive (pancreatic cancer, biliary tract cancer, gastric cancer, tubal cancer, esophageal cancer, ovarian cancer, cervical cancer, and triple-negative breast cancer). This evidence concerns the gene MSLN and familial pancreatic carcinoma.